0001209191-23-035691.txt : 20230609
0001209191-23-035691.hdr.sgml : 20230609
20230609143221
ACCESSION NUMBER: 0001209191-23-035691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fust Matthew K
CENTRAL INDEX KEY: 0001397266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 231004870
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-07
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001397266
Fust Matthew K
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
1
0
0
0
0
Common Stock
2023-06-07
4
A
0
3860
0.00
A
30355
D
Common Stock
2023-06-07
4
D
0
3300
51.82
D
27055
D
Stock Option (Right to Buy)
51.82
2023-06-07
4
A
0
7110
0.00
A
2033-06-07
Common Stock
7110
7110
D
Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.
Shares were acquired upon the vesting of a previously reported RSU and were disposed of to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person.
The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.
/s/ Karah Parschauer, attorney-in-fact
2023-06-09